Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acculis Limited
Liver Cancer Hope - Acculis Microwave Tissue Ablation System worldwide launch extended in Europe, the Americas and Asia
January 9th, 2009
Acculis Limited, the leading UK microwave ablation system company, announced the extension of the worldwide launch of their pioneering Microwave Tissue Ablation (MTA) system for the coagulation of soft tissue in open surgery. The system is being used by the world’s best liver surgeons to treat liver cancers. MTA is the only FDA 510(k) cleared single needle high power 2.45GHz microwave system. It achieves 5cm x 6.5cm coagulations with single 8 minute applications and 4.3cm x 6cm diameter coagulations in only 4 minutes. The simple to use MTA system surpasses contemporary low power 915MHz microwave systems which require complex multiple needle placements and longer times...
Source: Health Business Week (2009-01-09)
|
